CY1113872T1 - Ενωσεις imidazo[1,2-a]pyrazine για την θεραπεια μολυνσεων απο ιους οπως ηπατιτιδα - Google Patents

Ενωσεις imidazo[1,2-a]pyrazine για την θεραπεια μολυνσεων απο ιους οπως ηπατιτιδα

Info

Publication number
CY1113872T1
CY1113872T1 CY20131100277T CY131100277T CY1113872T1 CY 1113872 T1 CY1113872 T1 CY 1113872T1 CY 20131100277 T CY20131100277 T CY 20131100277T CY 131100277 T CY131100277 T CY 131100277T CY 1113872 T1 CY1113872 T1 CY 1113872T1
Authority
CY
Cyprus
Prior art keywords
treatment
virus infection
imidazo
pyrazine compounds
compounds
Prior art date
Application number
CY20131100277T
Other languages
English (en)
Inventor
Angus Macleod
Dale Robert Mitchell
Nicholas John Palmer
Christophe Claude Parsy
Michael Daniel Goldsmith
Clifford John Harris
Original Assignee
Biofocus Dpi Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofocus Dpi Limited filed Critical Biofocus Dpi Limited
Publication of CY1113872T1 publication Critical patent/CY1113872T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Abstract

Κοινοποιούνται καινούργιες ενώσεις imidazopyrazine που έχουν ένα τύπο που απεικονίζεται από τον ακόλουθο: Τύπο (I). Οι ενώσεις μπορούν να παρασκευαστούν σαν φαρμακευτικές συνθέσεις και μπορούν να χρησιμοποιηθούν για την πρόληψη και την θεραπεία μιας μόλυνσης από ιούς, ειδικότερα HCV, HRV, Sb και/ ή CVB σε ένα ασθενή που το έχει ανάγκη.
CY20131100277T 2007-08-21 2013-04-03 Ενωσεις imidazo[1,2-a]pyrazine για την θεραπεια μολυνσεων απο ιους οπως ηπατιτιδα CY1113872T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0716292.8A GB0716292D0 (en) 2007-08-21 2007-08-21 Imidazopyrazine compounds
EP08787346A EP2193131B1 (en) 2007-08-21 2008-08-20 Imidazo[1,2-a]pyrazine compounds for treatment of viral infections such as hepatitis

Publications (1)

Publication Number Publication Date
CY1113872T1 true CY1113872T1 (el) 2016-07-27

Family

ID=38566736

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100277T CY1113872T1 (el) 2007-08-21 2013-04-03 Ενωσεις imidazo[1,2-a]pyrazine για την θεραπεια μολυνσεων απο ιους οπως ηπατιτιδα

Country Status (21)

Country Link
US (1) US8362018B2 (el)
EP (2) EP2567960A3 (el)
JP (1) JP2010536825A (el)
KR (1) KR20100081294A (el)
CN (1) CN101835780B (el)
AU (1) AU2008290531A1 (el)
BR (1) BRPI0815717A2 (el)
CA (1) CA2707521A1 (el)
CY (1) CY1113872T1 (el)
DK (1) DK2193131T3 (el)
ES (1) ES2404415T3 (el)
GB (1) GB0716292D0 (el)
HK (1) HK1143810A1 (el)
HR (1) HRP20130202T1 (el)
MX (1) MX2010001733A (el)
NZ (1) NZ584108A (el)
PL (1) PL2193131T3 (el)
PT (1) PT2193131E (el)
SI (1) SI2193131T1 (el)
WO (1) WO2009024585A2 (el)
ZA (1) ZA201002009B (el)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0716292D0 (en) * 2007-08-21 2007-09-26 Biofocus Dpi Ltd Imidazopyrazine compounds
CA2722923C (en) 2008-04-29 2016-08-02 Boehringer Ingelheim International Gmbh Indazole compounds as ccr1 receptor antagonists
EP2297112B1 (en) 2008-05-06 2013-04-03 Boehringer Ingelheim International GmbH Pyrazole compounds as ccr1 antagonists
MX2011002951A (es) 2008-09-26 2011-04-26 Boehringer Ingelheim Int Compuestos de azaindazol como antagonistas del receptor de ccr1.
TW201107329A (en) 2009-07-30 2011-03-01 Oncotherapy Science Inc Fused imidazole derivative having ttk inhibitory action
GEP20146103B (en) 2009-10-21 2014-05-27 Boehringer Ingelheim Int Indazole and pyrazolopyridine compounds as ccr1 receptor antagonists
JP5542214B2 (ja) 2009-10-27 2014-07-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｃｒ１受容体アンタゴニストとしての複素環化合物
EP2493889B1 (en) 2009-10-30 2017-09-06 Janssen Pharmaceutica, N.V. IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
EA201200820A1 (ru) * 2009-12-08 2013-01-30 Бёрингер Ингельхайм Интернациональ Гмбх Способ синтеза промежуточных продуктов, применимых для получения замещенных индазолов и азаиндазолов
AR080754A1 (es) 2010-03-09 2012-05-09 Janssen Pharmaceutica Nv Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
CA2793279A1 (en) 2010-03-18 2011-09-22 Ulrich Klar Imidazopyrazines
US8871786B2 (en) 2010-04-30 2014-10-28 Boehringer Ingelheim International Gmbh Azaindazole amide compounds as CCR1 receptor antagonists
CA2801031A1 (en) 2010-06-01 2011-12-08 Bayer Intellectual Property Gmbh Substituted imidazopyrazines
JP2013545779A (ja) * 2010-12-17 2013-12-26 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 過剰増殖性障害の治療におけるｍｐｓ−１およびｔｋｋ阻害剤として使用するための６置換イミダゾピラジン
CA2821829A1 (en) * 2010-12-17 2012-06-21 Bayer Intellectual Property Gmbh Imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
CN103429591A (zh) 2010-12-17 2013-12-04 拜耳知识产权有限责任公司 在治疗过度增殖性病症中用作mps-1和tkk抑制剂的6-取代的咪唑并吡嗪
CN103370322B (zh) * 2010-12-17 2016-02-10 拜耳知识产权有限责任公司 在过度增殖性病症的治疗中用作mps-1和tkk抑制剂的2-取代的咪唑并吡嗪
ES2530802T3 (es) * 2010-12-17 2015-03-06 Bayer Ip Gmbh Imidazopirazinas 6-tiosustituidas para uso como inhibidores de MPS-1 y TKK en el tratamiento de trastornos hiperproliferativos
US9284317B2 (en) * 2010-12-17 2016-03-15 Bayer Intellectual Property Gmbh Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitors
WO2012087782A1 (en) 2010-12-23 2012-06-28 Boehringer Ingelheim International Gmbh Pyrazolopiperidine compounds as ccr1 receptor antagonists
GB201109763D0 (en) * 2011-06-10 2011-07-27 Ucl Business Plc Compounds
CA2838645C (en) 2011-06-27 2020-03-10 Janssen Pharmaceutica Nv 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives
CA2853221A1 (en) * 2011-10-24 2013-05-02 Tohru Yamashita Bicyclic compound
RU2657540C2 (ru) 2012-06-26 2018-06-14 Янссен Фармацевтика Нв Комбинации, содержащие ингибиторы pde 2, такие как 1-арил-4-метил-[1,2,4]триазоло[4,3-а]хиноксалиновые соединения, и ингибиторы pde 10, для применения в лечении неврологических или метаболических расстройств
ES2607184T3 (es) 2012-07-09 2017-03-29 Janssen Pharmaceutica, N.V. Inhibidores de la enzima fosfodiesterasa 10
WO2016130501A1 (en) 2015-02-09 2016-08-18 Incyte Corporation Aza-heteroaryl compounds as pi3k-gamma inhibitors
SI3288940T1 (sl) 2015-04-29 2021-07-30 Janssen Pharmaceutica Nv Azabenzimidazoli in njihova uporaba kot modulatorji AMPA-receptorja
JP6800885B2 (ja) * 2015-04-29 2020-12-16 ヤンセン ファーマシューティカ エヌ．ベー． イミダゾピラジン及びピラゾロピリミジン、並びにａｍｐａ受容体調節物質としてのこれらの使用
EP3313842B1 (en) * 2015-06-24 2020-04-15 Curovir Ab Pyrazolo[1,5-a]triazin-4-amine derivatives useful in therapy
JP6507976B2 (ja) * 2015-09-30 2019-05-08 東レ株式会社 イミダゾール−２−カルボン酸エステル誘導体又はその塩の製造方法
SI3371190T1 (sl) 2015-11-06 2022-08-31 Incyte Corporation Heterociklične spojine kot inhibitorji PI3K gama
AR107293A1 (es) 2016-01-05 2018-04-18 Incyte Corp COMPUESTOS DE PIRIDINA Y PIRIDIMINA COMO INHIBIDORES DE PI3K-g
ES2810303T3 (es) * 2016-03-31 2021-03-08 Romark Laboratories Lc Compuestos de tiazolida para tratar infecciones virales
TW201803871A (zh) 2016-06-24 2018-02-01 英塞特公司 作為ＰＩ３Ｋ-γ抑制劑之雜環化合物
UY37381A (es) 2016-08-30 2018-03-23 Glaxosmithkline Ip No 2 Ltd Compuestos que inhiben proteasas 3c y 3cl y métodos de uso de los mismos
EP4006034A1 (en) 2017-10-18 2022-06-01 Incyte Corporation Condensed imidazole derivatives substituted by tertiary hydroxy groups as pi3k-gamma inhibitors
TWI795510B (zh) 2018-01-17 2023-03-11 英商葛蘭素史密斯克藍智慧財產發展有限公司 PI4KIIIβ抑制劑
JP7309725B2 (ja) 2018-08-21 2023-07-18 杏林製薬株式会社 ２環性ヘテロ芳香環誘導体
RS65334B1 (sr) 2018-09-05 2024-04-30 Incyte Corp Kristalni oblici inhibitora fosfatidilinozitol 3-kinaze (pi3k)
CN109369545B (zh) * 2018-12-14 2020-04-10 东营曜康医药科技有限公司 2-甲基-5-甲酸吡嗪的合成工艺
US20230014730A1 (en) 2019-09-23 2023-01-19 Nanjing Zhengxiang Pharmaceuticals Co., Ltd. Phosphodiesterase inhibitors and use
EP4161930A1 (en) * 2020-06-08 2023-04-12 F. Hoffmann-La Roche AG Novel imidazo-pyrazine derivatives
CN113929633A (zh) * 2021-10-27 2022-01-14 山东大学 一种法匹拉韦的合成方法及其应用
CN113831255B (zh) * 2021-11-25 2022-03-11 山东诚创蓝海医药科技有限公司 一种2-氨基丙二酰胺的制备方法
CN115489188B (zh) * 2022-10-09 2023-08-29 安徽国风新材料股份有限公司 一种家居保护用聚酯薄膜及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2607813B1 (fr) * 1986-12-05 1989-03-31 Montpellier I Universite Alkylamino-8 imidazo (1,2-a) pyrazines et derives, leur preparation et leur application en therapeutique
DE19915178A1 (de) 1999-04-03 2000-10-05 Univ Mainz Johannes Gutenberg Hepatitis C Virus Zellkultursystem
JP4095303B2 (ja) 2000-05-23 2008-06-04 ワシントン・ユニバーシティ Ｈｃｖ変異体
AU2002225895A1 (en) 2000-11-07 2002-05-21 Anadys Pharmaceuticals, Inc. Hepatitis c virus constructs characterized by high efficiency replication
MXPA03005638A (es) 2000-12-22 2004-04-05 Boehringer Ingelheim Ca Ltd Auto replicacion de la molecula de arn de virus de la hepatitis c.
CA2434845C (en) 2001-01-23 2013-11-19 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Hepatitis c virus replicons and replicon enhanced cells
WO2002060492A1 (en) * 2001-01-30 2002-08-08 Cytopia Pty Ltd Methods of inhibiting kinases
AU2007200401A1 (en) * 2002-09-23 2007-02-22 Schering Corporation Imidazopyrazines as cyclin dependent kinase inhibitors
MY134589A (en) * 2002-09-23 2007-12-31 Schering Corp Imidazopyrazines as cyclin dependent kinase inhibitors
US7576085B2 (en) * 2002-09-23 2009-08-18 Schering Corporation Imidazopyrazines as cyclin dependent kinase inhibitors
DE602004024658D1 (de) 2003-02-13 2010-01-28 Merck & Co Inc Verfahren zur vermittlung von zellkulturreplikationsaktivität an unterschiedliche hepatitis-c-virus-isolate
AR043002A1 (es) 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
US7186832B2 (en) * 2003-02-20 2007-03-06 Sugen Inc. Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
US7157460B2 (en) * 2003-02-20 2007-01-02 Sugen Inc. Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
TW200803863A (en) * 2005-11-10 2008-01-16 Schering Corp Method for inhibiting protein kinases
CA2628455A1 (en) 2005-11-10 2007-05-24 Schering Corporation Imidazopyrazines as protein kinase inhibitors
US20100144743A1 (en) 2006-09-05 2010-06-10 Board Of Regents, The University Of Texas System Compositions and methods for inhibition of tyrosine kinases
EP2364702A3 (en) * 2006-09-05 2012-01-25 Emory University Kinase inhibitors for preventing or treating pathogen infection and method of use thereof
AR063581A1 (es) 2006-11-08 2009-02-04 Schering Corp Imidazopirazinas como inhibidores de proteina quinasa
WO2008059373A1 (en) 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
US8243049B2 (en) 2006-12-20 2012-08-14 3M Innovative Properties Company Untethered stylus employing low current power converter
GB0716292D0 (en) * 2007-08-21 2007-09-26 Biofocus Dpi Ltd Imidazopyrazine compounds

Also Published As

Publication number Publication date
JP2010536825A (ja) 2010-12-02
BRPI0815717A2 (pt) 2015-02-10
EP2567960A2 (en) 2013-03-13
DK2193131T3 (da) 2013-04-22
EP2567960A3 (en) 2013-06-05
HK1143810A1 (en) 2011-01-14
CN101835780B (zh) 2013-09-18
NZ584108A (en) 2012-06-29
WO2009024585A2 (en) 2009-02-26
US8362018B2 (en) 2013-01-29
EP2193131B1 (en) 2013-01-30
CN101835780A (zh) 2010-09-15
GB0716292D0 (en) 2007-09-26
MX2010001733A (es) 2010-07-06
PL2193131T3 (pl) 2013-07-31
HRP20130202T1 (hr) 2013-04-30
WO2009024585A3 (en) 2009-08-06
US20110166147A1 (en) 2011-07-07
ZA201002009B (en) 2010-12-29
EP2193131A2 (en) 2010-06-09
ES2404415T3 (es) 2013-05-27
AU2008290531A1 (en) 2009-02-26
CA2707521A1 (en) 2009-02-26
SI2193131T1 (sl) 2013-06-28
KR20100081294A (ko) 2010-07-14
PT2193131E (pt) 2013-04-04

Similar Documents

Publication Publication Date Title
CY1113872T1 (el) Ενωσεις imidazo[1,2-a]pyrazine για την θεραπεια μολυνσεων απο ιους οπως ηπατιτιδα
EA201000105A1 (ru) Химические соединения
EA200901241A1 (ru) Соединения для лечения гепатита с
EA201391519A1 (ru) 2'-замещенные нуклеозидные производные и способы их применения для лечения вирусных заболеваний
EA200802213A1 (ru) Способы лечения заболеваний крови
CY1113766T1 (el) Παραγωγα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων
EA201100390A1 (ru) Соединения для лечения гепатита с
EA201100794A1 (ru) Замещенные пиримидины, предназначенные для лечения заболеваний, таких как рак
CY1119269T1 (el) Θεραπεια βλαβων που προκαλουνται απο ιους
BRPI0418251A (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais
ECSP12012147A (es) Compuestos de sililo tricíclicos fusionados y métodos de uso de los mismos para el tratamiento de enfermedades virales
EA200800172A1 (ru) 2,4-диаминопиримидины как ингибиторы aurora
EA200900072A1 (ru) Фенилзамещенные гетероарильные производные и их применение в качестве противоопухолевых средств
EA201070597A1 (ru) Антибактериальные аналоги аминогликозида
CY1110835T1 (el) Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c
EA201100564A1 (ru) Антипролиферативные соединения
DK2203430T3 (da) N-phenyl-dioxo-hydropyrimidiner anvendelige som inhibitorer for hepatitis C virus (HCV)
EA201200890A1 (ru) Комбинированная терапия hcv
WO2012018534A3 (en) Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
EA200900638A1 (ru) СОЛИ И КРИСТАЛЛИЧЕСКИЕ ФОРМЫ 2-МЕТИЛ-2-[4-(3-МЕТИЛ-2-ОКСО-8-ХИНОЛИН-3-ИЛ-2,3-ДИГИДРОИМИДАЗО[4,5-c]ХИНОЛИН-1-ИЛ)ФЕНИЛ]ПРОПИОНИТРИЛА
CY1107084T1 (el) Παραγωγα πυρρολοπυριδαζινης
EA201100255A1 (ru) 5-алкинилпиримидины
MA32787B1 (fr) Peptides antiviraux therapeutiques
CY1113059T1 (el) Οργανικες ενωσεις
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate